Microfluidic system incorporates neuroinflammation into "Alzheimer's in a dish" model
System fully replicates Alzheimer's pathology, including neural cell death
Chinese scientists snip mutant DNA to fix human embryo gene
Researchers report success with technique to replace part of genetic material that causes the inheritable disorder Marfan syndrome
Gene therapy method developed to target damaged kidney cells
Discovery may lead to improved treatment for chronic kidney disease
Researchers discover gene that controls bone-to-fat ratio in bone marrow
In an unexpected discovery, UCLA researchers have found that a gene previously known to control human metabolism also controls the equilibrium of bone and fat in bone marrow as well as how an adult stem cell expresses its final cell type.
Probe illuminates Elusive Cancer Stem Cells in Live Mice
University of Illinois researchers have developed a molecular probe that seeks out these elusive cells and lights them up so they can be identified, tracked and studied not only in cell cultures, but in their native environment: the body.
Stem cell transplants to be used in treating Crohn's disease
A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn's disease -- a painful and chronic intestinal disease which affects at least 115,000 people in the UK
Those with MS Are Cautioned About Unsafe Stem Cell Treatments
People with multiple sclerosis sometimes become desperate and will travel to other countries for experimental stem cell treatments. That?s not always a good idea.
Researchers identify protein essential for making stem cells
The discovery by Stanford scientists drills a peephole into the black box of cellular reprogramming and may lead to new ways to generate induced pluripotent stem cells in the laboratory.
Stem cell mutations linked to hydrocephalus
A new genetic study found another explanation, Yale University researchers report July 5 in the journal Neuron.
Virus-free CRISPR could mean faster, more precise gene editing for T-cell therapies
A team from the University of California, San Francisco, devised a new electroporation-based CRISPR-Cas9 method, eliminating viruses from the gene editing process and laying the groundwork for safer, more precise and more efficient editing for CAR-T cancer treatments and other cell therapies.